Advanced or Metastatic Solid Tumors Recruiting Phase 1 / 2 Trials for Cemiplimab (DB14707)

IndicationStatusPhase
DBCOND0034454 (Advanced or Metastatic Solid Tumors)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03684785Intratumoral Cavrotolimod Combined With Pembrolizumab or Cemiplimab in Patients With Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, or Other Advanced Solid TumorsTreatment